pamidronate has been researched along with prednisolone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 8 (50.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Banham, SW; Boyle, IT; Campbell, JH; Ralston, S | 1 |
| Boyle, IT; Cowan, RA; Dryburgh, FJ; Gardner, MD; Jenkins, AS; Ralston, SH | 1 |
| Body, JJ; des Grottes, JM; Dumon, JC; Schrooyen, M | 1 |
| Casson, IF; Fraser, WD; Sinha, RN | 1 |
| Akyüz, C; Büyükpamukçu, M; Hazar, V; Kutluk, MT; Varan, A | 1 |
| Boutsen, Y; Devogelaer, JP; Esselinckx, W; Jamart, J; Stoffel, M | 1 |
| Abildgaard, N; Brincker, H; Ford, J; Gimsing, P; Hedenus, M; Kandra, A; Turesson, I; Westin, J | 1 |
| Adams, JE; Freemont, TJ; Haworth, CS; Selby, PL; Webb, AK | 1 |
| Bellido, T; Manolagas, SC; Parfitt, AM; Plotkin, LI; Roberson, PK; Weinstein, RS | 1 |
| Boutsen, Y; Devogelaer, JP; Esselinckx, W; Jamart, J | 1 |
| Aburano, T; Inaoka, T; Ishikawa, Y; Makita, Y; Sato, J; Shuke, N; Takahashi, K | 1 |
| Kondo, H; Kubota, M; Mori, A | 1 |
| Palimar, P; Quah, S; Ramasamy, B; Sahni, JN | 1 |
| Eun Young, H; Hyeyun, K; Sang Hee, I | 1 |
1 review(s) available for pamidronate and prednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for pamidronate and prednisolone
| Article | Year |
|---|---|
Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.
Topics: Calcitonin; Calcium; Clinical Trials as Topic; Creatinine; Diphosphonates; Drug Therapy, Combination; Humans; Hypercalcemia; Neoplasms; Pamidronate; Plicamycin; Prednisolone; Random Allocation | 1985 |
Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial.
Topics: Absorptiometry, Photon; Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Bone Density; Calcium; Diphosphonates; Female; Femur; Humans; Injections, Intravenous; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Pamidronate; Prednisolone; Time Factors; Treatment Outcome | 1997 |
Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double-blind placebo-controlled trial. Danish-Swedish co-operative study group.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Body Height; Bone Diseases; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Hypercalcemia; Male; Melphalan; Multiple Myeloma; Pain; Pamidronate; Prednisolone; Treatment Failure | 1998 |
Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
Topics: Alkaline Phosphatase; Bone Density; Bone Remodeling; Calcium; Collagen; Collagen Type I; Diphosphonates; Dose-Response Relationship, Drug; Female; Femur; Glucocorticoids; Hip Joint; Humans; Infusions, Intravenous; Lumbar Vertebrae; Male; Matched-Pair Analysis; Middle Aged; Osteocalcin; Osteoporosis; Pamidronate; Peptides; Prednisolone; Prospective Studies; Random Allocation; Time Factors | 2001 |
Pamidronate effect compared with a steroid on complex regional pain syndrome type I: Pilot randomised trial.
Topics: Administration, Intravenous; Adult; Aged; Bone Density Conservation Agents; Diphosphonates; Female; Glucocorticoids; Hand; Hemiplegia; Humans; Male; Middle Aged; Pain Measurement; Pamidronate; Pilot Projects; Prednisolone; Reflex Sympathetic Dystrophy; Stroke; Treatment Outcome | 2016 |
10 other study(ies) available for pamidronate and prednisolone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Symptomatic hypercalcaemia in lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Diphosphonates; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Lung Neoplasms; Male; Middle Aged; Pamidronate; Plicamycin; Prednisolone; Prognosis | 1991 |
Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria.
Topics: Anti-Inflammatory Agents; Diphosphonates; Evoked Potentials, Visual; Female; Humans; Infusions, Intravenous; Middle Aged; Optic Neuritis; Osteoporosis, Postmenopausal; Pamidronate; Porphyrias; Prednisolone | 1997 |
Long-term management of hypercalcaemia in chronically active sarcoidosis.
Topics: Adult; Chronic Disease; Diphosphonates; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Hydroxychloroquine; Hypercalcemia; Kidney Failure, Chronic; Lymphatic Diseases; Pamidronate; Prednisolone; Sarcoidosis | 1997 |
Childhood cancer and hypercalcemia: report of a case treated with pamidronate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Child, Preschool; Diphosphonates; Glucocorticoids; Humans; Hypercalcemia; Lymphoma, Non-Hodgkin; Male; Pamidronate; Prednisolone | 1997 |
Oral corticosteroids and bone pain after pamidronate in adults with cystic fibrosis.
Topics: Adult; Anti-Infective Agents; Bone Diseases; Cystic Fibrosis; Diphosphonates; Glucocorticoids; Humans; Pain; Pamidronate; Prednisolone | 1999 |
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin.
Topics: Alendronate; Animals; Apoptosis; Calcitonin; Cell Line; Cells, Cultured; Dexamethasone; Diphosphonates; Etidronic Acid; Etoposide; In Situ Nick-End Labeling; Mice; Osteoblasts; Osteocytes; Pamidronate; Prednisolone; Skull; Tumor Necrosis Factor-alpha | 1999 |
Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati-Engelmann disease).
Topics: Administration, Oral; Adult; Camurati-Engelmann Syndrome; Diphosphonates; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Pain Measurement; Pain, Intractable; Pamidronate; Prednisolone; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2001 |
Maintenance with pamidronate following first-line MP or VAD therapy in multiple myeloma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Dexamethasone; Diphosphonates; Doxorubicin; Drug Evaluation; Female; Hemoglobins; Humans; Immunoglobulins; Male; Melphalan; Middle Aged; Multiple Myeloma; Pamidronate; Plasma Cells; Prednisolone; Prospective Studies; Vincristine | 2003 |
Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost.
Topics: Acute Disease; Administration, Topical; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density Conservation Agents; Diphosphonates; Drug Interactions; Female; Fibrin; Glaucoma, Open-Angle; Humans; Infusions, Intravenous; Latanoprost; Osteoporosis, Postmenopausal; Pamidronate; Prednisolone; Prostaglandins F, Synthetic; Recurrence; Uveitis, Anterior | 2007 |